An analysis of nearly 10,000 people taking semaglutide drugs found they lost on average 10.2-13.2% of baseline weight over 12 months.(8) Its important to note that GLP-1 clinical trials employ run-in periods where non-adherent participants are excluded.(9) Real world patients face many barriers to consistent adherence, including side effects, injection anxieties, medication costs and behavioral challenges
Online GLP-1 providers are licensed telehealth companies that help people get prescription weight loss medicine like semaglutide and tirzepatide from home
Uamek-Kozio, M., Czuczwar, S
They creep in as fatigue you blame on poor sleep, or digestive issues you attribute to something you ate
Their similarities often lead to comparisons, but their development history, approved uses, and available clinical evidence are quite different